Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...